CN102030738A
|
|
Novel imidazole compound, preparation method and use thereof
|
EP2289867A2
|
|
A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof
|
WO2010084516A1
|
|
Process for producing optically active n-alkyl-piperidine-2-carboxanilide
|
CN101774966A
|
|
Process for producing dihalopyridines
|
WO2010046932A2
|
|
Extended release pharmaceutical composition of minocycline and process thereof
|
WO2010041277A2
|
|
Stable pharmaceutical compositions of montelukast or its salts or solvates or hydrates
|
WO2010023535A1
|
|
A process for producing (s)-3-[(1-dimethylamino)ethyl] phenyl-n-ethyl-n-methyl-carbamate via novel intermediates
|
CN101723885A
|
|
Improved method for preparing diaminopyridine
|
US2010285119A1
|
|
Multiparticulate Extended Release Pharmaceutical Composition Of Carbamazepine And Process For Manufacturing The Same
|
CN101544635A
|
|
Improved method for preparing 10-halo-benzo[b][1,5]naphthyridine
|
US2010291225A1
|
|
Stabilized Sustained Release Composition of Bupropion Hydrochloride and Process For Preparing the Same
|
WO2008104996A2
|
|
Water dispersible pharmaceutical formulation and process for preparing the same
|
WO2008023390A2
|
|
Modified release pharmaceutical composition of bupropion hydrochloride
|
EP2054403A1
|
|
Process for producing sulphoxide compounds
|
CA2658675A1
|
|
Process for producing 10-oxo-10, 11-dihydr0-5h-dibenz [b, f] azepine-5-carboxamide starting from 5-cyanoiminostilbene
|
WO2008126098A1
|
|
Extended release pharmaceutical formulation of propranolol hydrochloride
|
WO2007144901A1
|
|
Process for stabilization of olanzapine polymorphic form i
|
WO2007141806A1
|
|
Pharmaceutical formulations comprising oxcarbazepine and methods thereof
|
WO2007129329A2
|
|
Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
|
WO2007108010A2
|
|
Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate
|